RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives $18.17 Average Target Price from Analysts
Source: Americanbankingnews
Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) have earned an average recommendation of “Hold” from the ten research firms that are covering the company, MarketBeat reports. Nine analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month target price among […]